Catalyst Wire Dossier Catalyst Wire Dossier

DBI-002 Probiotic

· DermBiont, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DBI-002 Probiotic, covering 2025-07-03 to 2025-07-03. Get the full timeline:

Most recent: Clinical Trial Update: A Trial to Evaluate the Safety and Antimicrobial Efficacy of DBI-002 Probiotic in Adults With Tinea Versicolor [Phase 2]

See pricing